Publication
Article
Pharmaceutical Technology
Author(s):
The new inorganic pyrophosphate from Canvax is intended for use in RNA IVT reactions.
Canvax Inorganic Pyrophosphotate
Canvax’s new inorganic pyrophosphatase is a DNA replication enhancer with ≥ 95% purity and has an enhanced capacity for increasing RNA yield in in-vitro transcription (IVT) reactions. The enzyme, which is isolated from Escherichia coli, has demonstrated stability below 80ºF, and is free of endonucleases, exonucleases, and RNAases.
The enzyme is intended for use in RNA IVT reactions, as it is designed to reduce the inhibitory effects of protein-protein interactions. In addition, it is suitable for use in messenger RNA-based vaccine manufacturing, RNA labeling, and enhancement of DNA replication.
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.